Discovering Factors in Narcolepsy Patients' Clinical Research Experiences
Launched by POWER LIFE SCIENCES INC. · May 12, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the experiences of patients living with narcolepsy, a condition that causes excessive daytime sleepiness and sudden sleep attacks. By participating in this study, patients can share their personal stories and insights, which will help researchers develop better treatments and support programs for those affected by narcolepsy. The trial is observational, meaning that it will gather information without giving participants any specific treatment.
To be eligible for the trial, participants need to be at least 18 years old and willing to follow the study's schedule and requirements. It's important that they can provide written consent to participate. However, women who are pregnant or breastfeeding, individuals unable to report their experiences electronically, or those who may be vulnerable to any interventions cannot take part. While the trial is not yet recruiting participants, it aims to create a platform for patients to voice their experiences, ultimately leading to improved care and understanding of narcolepsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is at least 18 years of age
- • Patient is able and willing to comply with the treatment/follow-up schedule and requirements
- • Patient must provide written informed consent
- Exclusion Criteria:
- • Women who are pregnant, intend to become pregnant, or are lactating
- • Inability to perform regular electronic reporting
- • Participants who are vulnerable to any intervention
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported